Your Top 100 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

Hervé Ghesquières, Marion Chevrier, Mouna Laadhari, Olivier Louis Chinot, Sylvain Choquet, Cécile Moluçon‐Chabrot and 15 more

Rank
51 of 4,622
Percentile
top 1.2%
Where
Annals of Oncology, 2019
Citations
246

From the 2019 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.